πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 29,054 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11618784

Anti-CD47 combination therapy

TEVA PHARMACEUTICALS AUSTRALIA PTY LTD Β· Granted Tue Apr 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11617755

Pharmaceutical compositions comprising meloxicam

AXSOME THERAPEUTICS, INC. Β· Granted Tue Apr 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11617756

Pharmaceutical compositions comprising meloxicam

AXSOME THERAPEUTICS, INC. Β· Granted Tue Apr 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11617761

Methods for treating NLRP3 inflammasome-associated diseases, and methods of identifying ag

The Regents of the University of California Β· Granted Tue Apr 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11617766

Notch receptors with hinge domain

The Regents of the University of California Β· Granted Tue Apr 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11617753

Methods of treating and inhibiting Ebola virus infection

The United States of America, as represented by the Secretary, Health and Human Services Β· Granted Tue Apr 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11618731

Prodrugs of kallikrein inhibitors

BioCryst Pharmaceuticals, Inc. Β· Granted Tue Apr 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11618733

Crystalline salts of a plasma kallikrein inhibitor

BioCryst Pharmaceuticals, Inc. Β· Granted Tue Apr 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11618746

Inhibitors of APOL1 and methods of using same

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11612657

Biodegradable lipids for the delivery of active agents

Alnylam Pharmaceuticals, Inc. Β· Granted Tue Mar 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11612662

Multi-arm polymeric prodrug conjugates of pemetrexed-based compounds

Nektar Therapeutics Β· Granted Tue Mar 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11612608

Methods of treating oral mucositis

Galera Labs, LLC Β· Granted Tue Mar 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11612663

Proteoglycan mimetics for enhanced wound healing, angiogenesis, and vascular repair

The Regents of the University of California Β· Granted Tue Mar 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11612870

Microencapsulation of chemicals and bioactives by in situ complex coacervation during spra

The Regents of the University of California Β· Granted Tue Mar 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11612675

Fish skin biologic bandage

The Regents of the University of California Β· Granted Tue Mar 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11613502

Core-shell ceramic particle colloidal gel and solid oxide fuel cell electrolyte

The Regents of the University of Colorado Β· Granted Tue Mar 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11613538

Method of inhibiting or reducing a viral infection

PTC THERAPEUTICS, INC. Β· Granted Tue Mar 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11613527

Enzyme inhibitors

KalVista Pharmaceuticals Limited Β· Granted Tue Mar 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11613511

Methods of making bempedoic acid and compositions of the same

Esperion Therapeutics, Inc. Β· Granted Tue Mar 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11613528

Small molecule inhibitors of shared epitope-calreticulin interactions and methods of use

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Mar 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11612652

Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dend

PDS Biotechnology Corporation Β· Granted Tue Mar 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11613735

Methods for reprograming non-hepatocyte cells into hepatocyte cells

BeiHao Stem Cell and Regenerative Medicine Translational Research Institute Β· Granted Tue Mar 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11612575

Combination therapies with disulfiram

Spring Discovery, Inc. Β· Granted Tue Mar 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11613754

Toxic RNAi active seed sequences for killing cancer cells

Northwestern University Β· Granted Tue Mar 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted